Andrew Mellor

Clinical Operations Project Manager

Image of Andrew Mellor
Is this your profile? Click to edit

Publications

  • NUDCD3 deficiency disrupts V(D)J recombination to cause SCID and Omenn syndrome. Sci Immunol. 2024 05 24; 9(95):eade5705.. View in PubMed
  • Meningeal dendritic cells drive neuropathic pain through elevation of the kynurenine metabolic pathway in mice. J Clin Invest. 2022 12 01; 132(23).. View in PubMed
  • Characterization of age-associated B cells in early drug-naïve rheumatoid arthritis patients. Immunology. 2023 04; 168(4):640-653.. View in PubMed
  • Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis. Arthritis Rheumatol. 2021 10; 73(10):1820-1830.. View in PubMed
  • The immunotherapeutic role of indoleamine 2,3-dioxygenase in head and neck squamous cell carcinoma: A systematic review. Clin Otolaryngol. 2021 09; 46(5):919-934.. View in PubMed
  • Indoleamine 2,3 dioxygenase, age, and immune activation in people living with HIV. J Investig Med. 2021 08; 69(6):1238-1244.. View in PubMed
  • STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function. Cell Mol Immunol. 2021 03; 18(3):632-643.. View in PubMed
  • Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment. Cell Death Differ. 2021 02; 28(2):715-729.. View in PubMed
  • Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity. J Immunother Cancer. 2020 08; 8(2).. View in PubMed
  • Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation. Am J Transplant. 2021 04; 21(4):1402-1414.. View in PubMed